We are proud to announce we served as exclusive financial advisor to IriSys, LLC (“IriSys”), a leading full-service contract development and manufacturing organization (“CDMO”) based in San Diego, CA, in connection with its strategic sale to Recro Pharma, Inc. (“Recro”), a publicly traded CDMO headquartered in Exton, PA.
Powered by its state-of-the-art manufacturing facility and equipment, IriSys provides regulatory consulting, formulation development, and GMP (Good Manufacturing Practices) manufacturing to clinical and commercial clients across the world.
“Bailey Southwell did an outstanding job throughout the entirety of the sale process and managed to generate a superior outcome for our employees and shareholders”, commented Gerald Yakatan, Chairman, CEO and Founder of IriSys. “BSC’s transaction and market expertise was integral in our efforts to identify the right partner and execute a deal on the best terms. The Bailey Southwell team would be a good choice with whom to consider partnering if your organization is considering a liquidity event.”